NCT02359032View on ClinicalTrials.gov

A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

ASP6858

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (1)

HA1 3UJ

Site GB44001, Harrow

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02359032 - A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects | Biotech Hunter | Biotech Hunter